Home / News / World News / Article /
Pfizer jab produces less antibodies against Delta variant: Lancet study
Updated On: 05 June, 2021 08:24 AM IST | London | Agencies
It also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time

Tunisians working in the tourism industry receive a dose of the Pfizer-BioNTech Covid-19 coronavirus vaccine on Friday in Tunis. Pic/AFP
People fully vaccinated by the Pfizer-BioNTech vaccine are likely to have more than five times lower levels of neutralising antibodies against the Delta variant first identified in India compared to the original strain, according to research published in The Lancet journal.
The study also shows that levels of these antibodies that are able to recognise and fight the virus are lower with increasing age, and that levels decline over time, providing additional evidence in support of plans to deliver a booster dose to vulnerable people.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

